Search

Your search keyword '"Eccles, Suzanne A."' showing total 784 results
Start Over Author "Eccles, Suzanne A."
784 results on '"Eccles, Suzanne A."'

2. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers

Author

Vlachogiannis, Georgios, Hedayat, Somaieh, Vatsiou, Alexandra, Jamin, Yann, Fernández-Mateos, Javier, Khan, Khurum, Lampis, Andrea, Eason, Katherine, Huntingford, Ian, Burke, Rosemary, Rata, Mihaela, Koh, Dow-Mu, Tunariu, Nina, Collins, David, Hulkki-Wilson, Sanna, Ragulan, Chanthirika, Spiteri, Inmaculada, Moorcraft, Sing Yu, Chau, Ian, Rao, Sheela, Watkins, David, Fotiadis, Nicos, Bali, Maria, Darvish-Damavandi, Mahnaz, Lote, Hazel, Eltahir, Zakaria, Smyth, Elizabeth C., Begum, Ruwaida, Clarke, Paul A., Hahne, Jens C., Dowsett, Mitchell, de Bono, Johann, Workman, Paul, Sadanandam, Anguraj, Fassan, Matteo, Sansom, Owen J., Eccles, Suzanne, Starling, Naureen, Braconi, Chiara, Sottoriva, Andrea, Robinson, Simon P., Cunningham, David, and Valeri, Nicola

Published
2018

3. MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in Cholangiocarcinoma

Author

Lampis, Andrea, Carotenuto, Pietro, Vlachogiannis, Georgios, Cascione, Luciano, Hedayat, Somaieh, Burke, Rosemary, Clarke, Paul, Bosma, Else, Simbolo, Michele, Scarpa, Aldo, Yu, Sijia, Cole, Rebecca, Smyth, Elizabeth, Mateos, Javier Fernández, Begum, Ruwaida, Hezelova, Blanka, Eltahir, Zakaria, Wotherspoon, Andrew, Fotiadis, Nicos, Bali, Maria Antonietta, Nepal, Chirag, Khan, Khurum, Stubbs, Mark, Hahne, Jens C., Gasparini, Pierluigi, Guzzardo, Vincenza, Croce, Carlo M., Eccles, Suzanne, Fassan, Matteo, Cunningham, David, Andersen, Jesper B., Workman, Paul, Valeri, Nicola, and Braconi, Chiara

Published
2018
Full Text
View/download PDF

11. Abstract LB234: Activation of the integrated stress response by the developmental HSF1 pathway inhibitor NXP800

Author

Powers, Marissa V., primary, Sharp, Swee Y., additional, Lampraki, Eirini-Maria, additional, Roe, Toby, additional, Pellegrino, Loredana, additional, Taskinen, Maria, additional, te Poele, Robert, additional, Raynaud, Florence, additional, Eccles, Suzanne, additional, Cheeseman, Matthew, additional, Jones, Keith, additional, Clarke, Paul A., additional, and Workman, Paul, additional

Published
2023
Full Text
View/download PDF

12. HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies

Author

Pasqua, A. Elisa, primary, Sharp, Swee Y., additional, Chessum, Nicola E. A., additional, Hayes, Angela, additional, Pellegrino, Loredana, additional, Tucker, Michael J., additional, Miah, Asadh, additional, Wilding, Birgit, additional, Evans, Lindsay E., additional, Rye, Carl S., additional, Mok, N. Yi, additional, Liu, Manjuan, additional, Henley, Alan T., additional, Gowan, Sharon, additional, De Billy, Emmanuel, additional, te Poele, Robert, additional, Powers, Marissa, additional, Eccles, Suzanne A., additional, Clarke, Paul A., additional, Raynaud, Florence I., additional, Workman, Paul, additional, Jones, Keith, additional, and Cheeseman, Matthew D., additional

Published
2023
Full Text
View/download PDF

13. Supplementary Figure 1 from Plasma Metabolomic Changes following PI3K Inhibition as Pharmacodynamic Biomarkers: Preclinical Discovery to Phase I Trial Evaluation

Author

Ang, Joo Ern, primary, Pandher, Rupinder, primary, Ang, Joo Chew, primary, Asad, Yasmin J., primary, Henley, Alan T., primary, Valenti, Melanie, primary, Box, Gary, primary, de Haven Brandon, Alexis, primary, Baird, Richard D., primary, Friedman, Lori, primary, Derynck, Mika, primary, Vanhaesebroeck, Bart, primary, Eccles, Suzanne A., primary, Kaye, Stan B., primary, Workman, Paul, primary, de Bono, Johann S., primary, and Raynaud, Florence I., primary

Published
2023
Full Text
View/download PDF

14. Data from The Aurora Kinase Inhibitor CCT137690 Downregulates MYCN and Sensitizes MYCN-Amplified Neuroblastoma In Vivo

Author

Faisal, Amir, primary, Vaughan, Lynsey, primary, Bavetsias, Vassilios, primary, Sun, Chongbo, primary, Atrash, Butrus, primary, Avery, Sian, primary, Jamin, Yann, primary, Robinson, Simon P., primary, Workman, Paul, primary, Blagg, Julian, primary, Raynaud, Florence I., primary, Eccles, Suzanne A., primary, Chesler, Louis, primary, and Linardopoulos, Spiros, primary

Published
2023
Full Text
View/download PDF

15. Supplementary Figure S1 from High Proliferation Rate and a Compromised Spindle Assembly Checkpoint Confers Sensitivity to the MPS1 Inhibitor BOS172722 in Triple-Negative Breast Cancers

Author

Anderhub, Simon J., primary, Mak, Grace Wing-Yan, primary, Gurden, Mark D., primary, Faisal, Amir, primary, Drosopoulos, Konstantinos, primary, Walsh, Katie, primary, Woodward, Hannah L., primary, Innocenti, Paolo, primary, Westwood, Isaac M., primary, Naud, Sébastien, primary, Hayes, Angela, primary, Theofani, Efthymia, primary, Filosto, Simone, primary, Saville, Harry, primary, Burke, Rosemary, primary, van Montfort, Rob L.M., primary, Raynaud, Florence I., primary, Blagg, Julian, primary, Hoelder, Swen, primary, Eccles, Suzanne A., primary, and Linardopoulos, Spiros, primary

Published
2023
Full Text
View/download PDF

16. Supplementary Figure 1 from Modulation of Plasma Metabolite Biomarkers of the MAPK Pathway with MEK Inhibitor RO4987655: Pharmacodynamic and Predictive Potential in Metastatic Melanoma

Author

Ang, Joo Ern, primary, Pal, Akos, primary, Asad, Yasmin J., primary, Henley, Alan T., primary, Valenti, Melanie, primary, Box, Gary, primary, de haven Brandon, Alexis, primary, Revell, Victoria L., primary, Skene, Debra J., primary, Venturi, Miro, primary, Rueger, Ruediger, primary, Meresse, Valerie, primary, Eccles, Suzanne A., primary, de Bono, Johann S., primary, Kaye, Stanley B., primary, Workman, Paul, primary, Banerji, Udai, primary, and Raynaud, Florence I., primary

Published
2023
Full Text
View/download PDF

17. Supplementary Figure Legends 1-5 from The Aurora Kinase Inhibitor CCT137690 Downregulates MYCN and Sensitizes MYCN-Amplified Neuroblastoma In Vivo

Author

Faisal, Amir, primary, Vaughan, Lynsey, primary, Bavetsias, Vassilios, primary, Sun, Chongbo, primary, Atrash, Butrus, primary, Avery, Sian, primary, Jamin, Yann, primary, Robinson, Simon P., primary, Workman, Paul, primary, Blagg, Julian, primary, Raynaud, Florence I., primary, Eccles, Suzanne A., primary, Chesler, Louis, primary, and Linardopoulos, Spiros, primary

Published
2023
Full Text
View/download PDF

18. Supplementary Table 3 from Plasma Metabolomic Changes following PI3K Inhibition as Pharmacodynamic Biomarkers: Preclinical Discovery to Phase I Trial Evaluation

Author

Ang, Joo Ern, primary, Pandher, Rupinder, primary, Ang, Joo Chew, primary, Asad, Yasmin J., primary, Henley, Alan T., primary, Valenti, Melanie, primary, Box, Gary, primary, de Haven Brandon, Alexis, primary, Baird, Richard D., primary, Friedman, Lori, primary, Derynck, Mika, primary, Vanhaesebroeck, Bart, primary, Eccles, Suzanne A., primary, Kaye, Stan B., primary, Workman, Paul, primary, de Bono, Johann S., primary, and Raynaud, Florence I., primary

Published
2023
Full Text
View/download PDF

19. Supplementary Table S1 from High Proliferation Rate and a Compromised Spindle Assembly Checkpoint Confers Sensitivity to the MPS1 Inhibitor BOS172722 in Triple-Negative Breast Cancers

Author

Anderhub, Simon J., primary, Mak, Grace Wing-Yan, primary, Gurden, Mark D., primary, Faisal, Amir, primary, Drosopoulos, Konstantinos, primary, Walsh, Katie, primary, Woodward, Hannah L., primary, Innocenti, Paolo, primary, Westwood, Isaac M., primary, Naud, Sébastien, primary, Hayes, Angela, primary, Theofani, Efthymia, primary, Filosto, Simone, primary, Saville, Harry, primary, Burke, Rosemary, primary, van Montfort, Rob L.M., primary, Raynaud, Florence I., primary, Blagg, Julian, primary, Hoelder, Swen, primary, Eccles, Suzanne A., primary, and Linardopoulos, Spiros, primary

Published
2023
Full Text
View/download PDF

20. Supplementary Table 1 from Plasma Metabolomic Changes following PI3K Inhibition as Pharmacodynamic Biomarkers: Preclinical Discovery to Phase I Trial Evaluation

Author

Ang, Joo Ern, primary, Pandher, Rupinder, primary, Ang, Joo Chew, primary, Asad, Yasmin J., primary, Henley, Alan T., primary, Valenti, Melanie, primary, Box, Gary, primary, de Haven Brandon, Alexis, primary, Baird, Richard D., primary, Friedman, Lori, primary, Derynck, Mika, primary, Vanhaesebroeck, Bart, primary, Eccles, Suzanne A., primary, Kaye, Stan B., primary, Workman, Paul, primary, de Bono, Johann S., primary, and Raynaud, Florence I., primary

Published
2023
Full Text
View/download PDF

21. Supplementary Table 5 from Plasma Metabolomic Changes following PI3K Inhibition as Pharmacodynamic Biomarkers: Preclinical Discovery to Phase I Trial Evaluation

Author

Ang, Joo Ern, primary, Pandher, Rupinder, primary, Ang, Joo Chew, primary, Asad, Yasmin J., primary, Henley, Alan T., primary, Valenti, Melanie, primary, Box, Gary, primary, de Haven Brandon, Alexis, primary, Baird, Richard D., primary, Friedman, Lori, primary, Derynck, Mika, primary, Vanhaesebroeck, Bart, primary, Eccles, Suzanne A., primary, Kaye, Stan B., primary, Workman, Paul, primary, de Bono, Johann S., primary, and Raynaud, Florence I., primary

Published
2023
Full Text
View/download PDF

22. Data from Enhanced Efficacy of IGF1R Inhibition in Pediatric Glioblastoma by Combinatorial Targeting of PDGFRα/β

Author

Bielen, Aleksandra, primary, Perryman, Lara, primary, Box, Gary M., primary, Valenti, Melanie, primary, de Haven Brandon, Alexis, primary, Martins, Vanessa, primary, Jury, Alexa, primary, Popov, Sergey, primary, Gowan, Sharon, primary, Jeay, Sebastien, primary, Raynaud, Florence I., primary, Hofmann, Francesco, primary, Hargrave, Darren, primary, Eccles, Suzanne A., primary, and Jones, Chris, primary

Published
2023
Full Text
View/download PDF

23. Supplementary Table 1 from Modulation of Plasma Metabolite Biomarkers of the MAPK Pathway with MEK Inhibitor RO4987655: Pharmacodynamic and Predictive Potential in Metastatic Melanoma

Author

Ang, Joo Ern, primary, Pal, Akos, primary, Asad, Yasmin J., primary, Henley, Alan T., primary, Valenti, Melanie, primary, Box, Gary, primary, de haven Brandon, Alexis, primary, Revell, Victoria L., primary, Skene, Debra J., primary, Venturi, Miro, primary, Rueger, Ruediger, primary, Meresse, Valerie, primary, Eccles, Suzanne A., primary, de Bono, Johann S., primary, Kaye, Stanley B., primary, Workman, Paul, primary, Banerji, Udai, primary, and Raynaud, Florence I., primary

Published
2023
Full Text
View/download PDF

24. Data from High Proliferation Rate and a Compromised Spindle Assembly Checkpoint Confers Sensitivity to the MPS1 Inhibitor BOS172722 in Triple-Negative Breast Cancers

Author

Anderhub, Simon J., primary, Mak, Grace Wing-Yan, primary, Gurden, Mark D., primary, Faisal, Amir, primary, Drosopoulos, Konstantinos, primary, Walsh, Katie, primary, Woodward, Hannah L., primary, Innocenti, Paolo, primary, Westwood, Isaac M., primary, Naud, Sébastien, primary, Hayes, Angela, primary, Theofani, Efthymia, primary, Filosto, Simone, primary, Saville, Harry, primary, Burke, Rosemary, primary, van Montfort, Rob L.M., primary, Raynaud, Florence I., primary, Blagg, Julian, primary, Hoelder, Swen, primary, Eccles, Suzanne A., primary, and Linardopoulos, Spiros, primary

Published
2023
Full Text
View/download PDF

25. Supplementary Figures 1-4 from Preclinical Pharmacology, Antitumor Activity, and Development of Pharmacodynamic Markers for the Novel, Potent AKT Inhibitor CCT128930

Author

Yap, Timothy A., primary, Walton, Mike I., primary, Hunter, Lisa-Jane K., primary, Valenti, Melanie, primary, de Haven Brandon, Alexis, primary, Eve, Paul D., primary, Ruddle, Ruth, primary, Heaton, Simon P., primary, Henley, Alan, primary, Pickard, Lisa, primary, Vijayaraghavan, Gowri, primary, Caldwell, John J., primary, Thompson, Neil T., primary, Aherne, Wynne, primary, Raynaud, Florence I., primary, Eccles, Suzanne A., primary, Workman, Paul, primary, Collins, Ian, primary, and Garrett, Michelle D., primary

Published
2023
Full Text
View/download PDF

26. Data from Plasma Metabolomic Changes following PI3K Inhibition as Pharmacodynamic Biomarkers: Preclinical Discovery to Phase I Trial Evaluation

Author

Ang, Joo Ern, primary, Pandher, Rupinder, primary, Ang, Joo Chew, primary, Asad, Yasmin J., primary, Henley, Alan T., primary, Valenti, Melanie, primary, Box, Gary, primary, de Haven Brandon, Alexis, primary, Baird, Richard D., primary, Friedman, Lori, primary, Derynck, Mika, primary, Vanhaesebroeck, Bart, primary, Eccles, Suzanne A., primary, Kaye, Stan B., primary, Workman, Paul, primary, de Bono, Johann S., primary, and Raynaud, Florence I., primary

Published
2023
Full Text
View/download PDF

27. Data from Modulation of Plasma Metabolite Biomarkers of the MAPK Pathway with MEK Inhibitor RO4987655: Pharmacodynamic and Predictive Potential in Metastatic Melanoma

Author

Ang, Joo Ern, primary, Pal, Akos, primary, Asad, Yasmin J., primary, Henley, Alan T., primary, Valenti, Melanie, primary, Box, Gary, primary, de haven Brandon, Alexis, primary, Revell, Victoria L., primary, Skene, Debra J., primary, Venturi, Miro, primary, Rueger, Ruediger, primary, Meresse, Valerie, primary, Eccles, Suzanne A., primary, de Bono, Johann S., primary, Kaye, Stanley B., primary, Workman, Paul, primary, Banerji, Udai, primary, and Raynaud, Florence I., primary

Published
2023
Full Text
View/download PDF

28. Supplementary Table 4 from Plasma Metabolomic Changes following PI3K Inhibition as Pharmacodynamic Biomarkers: Preclinical Discovery to Phase I Trial Evaluation

Author

Ang, Joo Ern, primary, Pandher, Rupinder, primary, Ang, Joo Chew, primary, Asad, Yasmin J., primary, Henley, Alan T., primary, Valenti, Melanie, primary, Box, Gary, primary, de Haven Brandon, Alexis, primary, Baird, Richard D., primary, Friedman, Lori, primary, Derynck, Mika, primary, Vanhaesebroeck, Bart, primary, Eccles, Suzanne A., primary, Kaye, Stan B., primary, Workman, Paul, primary, de Bono, Johann S., primary, and Raynaud, Florence I., primary

Published
2023
Full Text
View/download PDF

29. Supplementary Figure 1 from Enhanced Efficacy of IGF1R Inhibition in Pediatric Glioblastoma by Combinatorial Targeting of PDGFRα/β

Author

Bielen, Aleksandra, primary, Perryman, Lara, primary, Box, Gary M., primary, Valenti, Melanie, primary, de Haven Brandon, Alexis, primary, Martins, Vanessa, primary, Jury, Alexa, primary, Popov, Sergey, primary, Gowan, Sharon, primary, Jeay, Sebastien, primary, Raynaud, Florence I., primary, Hofmann, Francesco, primary, Hargrave, Darren, primary, Eccles, Suzanne A., primary, and Jones, Chris, primary

Published
2023
Full Text
View/download PDF

30. Supplementary Figures 1-5 from The Aurora Kinase Inhibitor CCT137690 Downregulates MYCN and Sensitizes MYCN-Amplified Neuroblastoma In Vivo

Author

Faisal, Amir, primary, Vaughan, Lynsey, primary, Bavetsias, Vassilios, primary, Sun, Chongbo, primary, Atrash, Butrus, primary, Avery, Sian, primary, Jamin, Yann, primary, Robinson, Simon P., primary, Workman, Paul, primary, Blagg, Julian, primary, Raynaud, Florence I., primary, Eccles, Suzanne A., primary, Chesler, Louis, primary, and Linardopoulos, Spiros, primary

Published
2023
Full Text
View/download PDF

31. Supplementary Figure 3 from Enhanced Efficacy of IGF1R Inhibition in Pediatric Glioblastoma by Combinatorial Targeting of PDGFRα/β

Author

Bielen, Aleksandra, primary, Perryman, Lara, primary, Box, Gary M., primary, Valenti, Melanie, primary, de Haven Brandon, Alexis, primary, Martins, Vanessa, primary, Jury, Alexa, primary, Popov, Sergey, primary, Gowan, Sharon, primary, Jeay, Sebastien, primary, Raynaud, Florence I., primary, Hofmann, Francesco, primary, Hargrave, Darren, primary, Eccles, Suzanne A., primary, and Jones, Chris, primary

Published
2023
Full Text
View/download PDF

32. Supplementary Figure 4 from Enhanced Efficacy of IGF1R Inhibition in Pediatric Glioblastoma by Combinatorial Targeting of PDGFRα/β

Author

Bielen, Aleksandra, primary, Perryman, Lara, primary, Box, Gary M., primary, Valenti, Melanie, primary, de Haven Brandon, Alexis, primary, Martins, Vanessa, primary, Jury, Alexa, primary, Popov, Sergey, primary, Gowan, Sharon, primary, Jeay, Sebastien, primary, Raynaud, Florence I., primary, Hofmann, Francesco, primary, Hargrave, Darren, primary, Eccles, Suzanne A., primary, and Jones, Chris, primary

Published
2023
Full Text
View/download PDF

33. Supplementary Figure 2 from Enhanced Efficacy of IGF1R Inhibition in Pediatric Glioblastoma by Combinatorial Targeting of PDGFRα/β

Author

Bielen, Aleksandra, primary, Perryman, Lara, primary, Box, Gary M., primary, Valenti, Melanie, primary, de Haven Brandon, Alexis, primary, Martins, Vanessa, primary, Jury, Alexa, primary, Popov, Sergey, primary, Gowan, Sharon, primary, Jeay, Sebastien, primary, Raynaud, Florence I., primary, Hofmann, Francesco, primary, Hargrave, Darren, primary, Eccles, Suzanne A., primary, and Jones, Chris, primary

Published
2023
Full Text
View/download PDF

34. Supplementary Table 2 from Plasma Metabolomic Changes following PI3K Inhibition as Pharmacodynamic Biomarkers: Preclinical Discovery to Phase I Trial Evaluation

Author

Ang, Joo Ern, primary, Pandher, Rupinder, primary, Ang, Joo Chew, primary, Asad, Yasmin J., primary, Henley, Alan T., primary, Valenti, Melanie, primary, Box, Gary, primary, de Haven Brandon, Alexis, primary, Baird, Richard D., primary, Friedman, Lori, primary, Derynck, Mika, primary, Vanhaesebroeck, Bart, primary, Eccles, Suzanne A., primary, Kaye, Stan B., primary, Workman, Paul, primary, de Bono, Johann S., primary, and Raynaud, Florence I., primary

Published
2023
Full Text
View/download PDF

35. Supplementary Figure Legends 1-4 from Enhanced Efficacy of IGF1R Inhibition in Pediatric Glioblastoma by Combinatorial Targeting of PDGFRα/β

Author

Bielen, Aleksandra, primary, Perryman, Lara, primary, Box, Gary M., primary, Valenti, Melanie, primary, de Haven Brandon, Alexis, primary, Martins, Vanessa, primary, Jury, Alexa, primary, Popov, Sergey, primary, Gowan, Sharon, primary, Jeay, Sebastien, primary, Raynaud, Florence I., primary, Hofmann, Francesco, primary, Hargrave, Darren, primary, Eccles, Suzanne A., primary, and Jones, Chris, primary

Published
2023
Full Text
View/download PDF

38. ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine glioma

Author

Carvalho, Diana, Taylor, Kathryn R., Olaciregui, Nagore Gene, Molinari, Valeria, Clarke, Matthew, Mackay, Alan, Ruddle, Ruth, Henley, Alan, Valenti, Melanie, Hayes, Angela, Brandon, Alexis De Haven, Eccles, Suzanne A., Raynaud, Florence, Boudhar, Aicha, Monje, Michelle, Popov, Sergey, Moore, Andrew S., Mora, Jaume, Cruz, Ofelia, Vinci, Mara, Brennan, Paul E., Bullock, Alex N., Carcaboso, Angel Montero, and Jones, Chris

Published
2019
Full Text
View/download PDF

39. Supplementary Figure Captions from Noninvasive Imaging of Cycling Hypoxia in Head and Neck Cancer Using Intrinsic Susceptibility MRI

Author

Panek, Rafal, primary, Welsh, Liam, primary, Baker, Lauren C.J., primary, Schmidt, Maria A., primary, Wong, Kee H., primary, Riddell, Angela M., primary, Koh, Dow-Mu, primary, Dunlop, Alex, primary, Mcquaid, Dualta, primary, d'Arcy, James A., primary, Bhide, Shreerang A., primary, Harrington, Kevin J., primary, Nutting, Christopher M., primary, Hopkinson, Georgina, primary, Richardson, Cheryl, primary, Box, Carol, primary, Eccles, Suzanne A., primary, Leach, Martin O., primary, Robinson, Simon P., primary, and Newbold, Kate L., primary

Published
2023
Full Text
View/download PDF

40. Supplementary Table 5A from AT13148 Is a Novel, Oral Multi-AGC Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity

Author

Yap, Timothy A., primary, Walton, Mike I., primary, Grimshaw, Kyla M., primary, te Poele, Robert H., primary, Eve, Paul D., primary, Valenti, Melanie R., primary, de Haven Brandon, Alexis K., primary, Martins, Vanessa, primary, Zetterlund, Anna, primary, Heaton, Simon P., primary, Heinzmann, Kathrin, primary, Jones, Paul S., primary, Feltell, Ruth E., primary, Reule, Matthias, primary, Woodhead, Steven J., primary, Davies, Thomas G., primary, Lyons, John F., primary, Raynaud, Florence I., primary, Eccles, Suzanne A., primary, Workman, Paul, primary, Thompson, Neil T., primary, and Garrett, Michelle D., primary

Published
2023
Full Text
View/download PDF

41. Supplementary Table and Figures from Dual Blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) Pathways Synergistically Inhibits Rhabdomyosarcoma Cell Growth In Vitro and In Vivo

Author

Renshaw, Jane, primary, Taylor, Kathryn R., primary, Bishop, Ryan, primary, Valenti, Melanie, primary, De Haven Brandon, Alexis, primary, Gowan, Sharon, primary, Eccles, Suzanne A., primary, Ruddle, Ruth R., primary, Johnson, Louise D., primary, Raynaud, Florence I., primary, Selfe, Joanna L., primary, Thway, Khin, primary, Pietsch, Torsten, primary, Pearson, Andrew D., primary, and Shipley, Janet, primary

Published
2023
Full Text
View/download PDF

42. CCR Translation for This Article from Dual Blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) Pathways Synergistically Inhibits Rhabdomyosarcoma Cell Growth In Vitro and In Vivo

Author

Renshaw, Jane, primary, Taylor, Kathryn R., primary, Bishop, Ryan, primary, Valenti, Melanie, primary, De Haven Brandon, Alexis, primary, Gowan, Sharon, primary, Eccles, Suzanne A., primary, Ruddle, Ruth R., primary, Johnson, Louise D., primary, Raynaud, Florence I., primary, Selfe, Joanna L., primary, Thway, Khin, primary, Pietsch, Torsten, primary, Pearson, Andrew D., primary, and Shipley, Janet, primary

Published
2023
Full Text
View/download PDF

43. Supplementary Figure 1 from Noninvasive Imaging of Cycling Hypoxia in Head and Neck Cancer Using Intrinsic Susceptibility MRI

Author

Panek, Rafal, primary, Welsh, Liam, primary, Baker, Lauren C.J., primary, Schmidt, Maria A., primary, Wong, Kee H., primary, Riddell, Angela M., primary, Koh, Dow-Mu, primary, Dunlop, Alex, primary, Mcquaid, Dualta, primary, d'Arcy, James A., primary, Bhide, Shreerang A., primary, Harrington, Kevin J., primary, Nutting, Christopher M., primary, Hopkinson, Georgina, primary, Richardson, Cheryl, primary, Box, Carol, primary, Eccles, Suzanne A., primary, Leach, Martin O., primary, Robinson, Simon P., primary, and Newbold, Kate L., primary

Published
2023
Full Text
View/download PDF

44. Supplementary Figure 2 from Noninvasive Imaging of Cycling Hypoxia in Head and Neck Cancer Using Intrinsic Susceptibility MRI

Author

Panek, Rafal, primary, Welsh, Liam, primary, Baker, Lauren C.J., primary, Schmidt, Maria A., primary, Wong, Kee H., primary, Riddell, Angela M., primary, Koh, Dow-Mu, primary, Dunlop, Alex, primary, Mcquaid, Dualta, primary, d'Arcy, James A., primary, Bhide, Shreerang A., primary, Harrington, Kevin J., primary, Nutting, Christopher M., primary, Hopkinson, Georgina, primary, Richardson, Cheryl, primary, Box, Carol, primary, Eccles, Suzanne A., primary, Leach, Martin O., primary, Robinson, Simon P., primary, and Newbold, Kate L., primary

Published
2023
Full Text
View/download PDF

46. Supplementary Figure 5 from CCT244747 Is a Novel Potent and Selective CHK1 Inhibitor with Oral Efficacy Alone and in Combination with Genotoxic Anticancer Drugs

Author

Walton, Mike I., primary, Eve, Paul D., primary, Hayes, Angela, primary, Valenti, Melanie R., primary, De Haven Brandon, Alexis K., primary, Box, Gary, primary, Hallsworth, Albert, primary, Smith, Elizabeth L., primary, Boxall, Kathy J., primary, Lainchbury, Michael, primary, Matthews, Thomas P., primary, Jamin, Yann, primary, Robinson, Simon P., primary, Aherne, G. Wynne, primary, Reader, John C., primary, Chesler, Louis, primary, Raynaud, Florence I., primary, Eccles, Suzanne A., primary, Collins, Ian, primary, and Garrett, Michelle D., primary

Published
2023
Full Text
View/download PDF

47. Supplementary Figure 2 from Biological properties of potent inhibitors of class I phosphatidylinositide 3-kinases: from PI-103 through PI-540, PI-620 to the oral agent GDC-0941

Author

Raynaud, Florence I., primary, Eccles, Suzanne A., primary, Patel, Sonal, primary, Alix, Sonia, primary, Box, Gary, primary, Chuckowree, Irina, primary, Folkes, Adrian, primary, Gowan, Sharon, primary, De Haven Brandon, Alexis, primary, Di Stefano, Francesca, primary, Hayes, Angela, primary, Henley, Alan T., primary, Lensun, Letitia, primary, Pergl-Wilson, Giles, primary, Robson, Anthony, primary, Saghir, Nahid, primary, Zhyvoloup, Alexander, primary, McDonald, Edward, primary, Sheldrake, Peter, primary, Shuttleworth, Stephen, primary, Valenti, Melanie, primary, Wan, Nan Chi, primary, Clarke, Paul A., primary, and Workman, Paul, primary

Published
2023
Full Text
View/download PDF

48. Supplementary Table 6A from AT13148 Is a Novel, Oral Multi-AGC Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity

Author

Yap, Timothy A., primary, Walton, Mike I., primary, Grimshaw, Kyla M., primary, te Poele, Robert H., primary, Eve, Paul D., primary, Valenti, Melanie R., primary, de Haven Brandon, Alexis K., primary, Martins, Vanessa, primary, Zetterlund, Anna, primary, Heaton, Simon P., primary, Heinzmann, Kathrin, primary, Jones, Paul S., primary, Feltell, Ruth E., primary, Reule, Matthias, primary, Woodhead, Steven J., primary, Davies, Thomas G., primary, Lyons, John F., primary, Raynaud, Florence I., primary, Eccles, Suzanne A., primary, Workman, Paul, primary, Thompson, Neil T., primary, and Garrett, Michelle D., primary

Published
2023
Full Text
View/download PDF

50. Supplementary Figure 3 from CCT244747 Is a Novel Potent and Selective CHK1 Inhibitor with Oral Efficacy Alone and in Combination with Genotoxic Anticancer Drugs

Author

Walton, Mike I., primary, Eve, Paul D., primary, Hayes, Angela, primary, Valenti, Melanie R., primary, De Haven Brandon, Alexis K., primary, Box, Gary, primary, Hallsworth, Albert, primary, Smith, Elizabeth L., primary, Boxall, Kathy J., primary, Lainchbury, Michael, primary, Matthews, Thomas P., primary, Jamin, Yann, primary, Robinson, Simon P., primary, Aherne, G. Wynne, primary, Reader, John C., primary, Chesler, Louis, primary, Raynaud, Florence I., primary, Eccles, Suzanne A., primary, Collins, Ian, primary, and Garrett, Michelle D., primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results